Overview

Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

Status:
RECRUITING
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This is a, open-label, single-arm 8-week investigation of levodopa/carbidopa/entacapone in the treatment of early Parkinson's disease.
Phase:
PHASE4
Details
Lead Sponsor:
Second Affiliated Hospital of Soochow University
Treatments:
Levodopa
Stalevo